▶ 調査レポート

世界の皮膚科用CRO市場 2028年:ドラッグサービス、臨床サービス、前臨床サービス

• 英文タイトル:Global Dermatology CRO Market Insights, Forecast to 2028

Global Dermatology CRO Market Insights, Forecast to 2028「世界の皮膚科用CRO市場 2028年:ドラッグサービス、臨床サービス、前臨床サービス」(市場規模、市場予測)調査レポートです。• レポートコード:QY2207C3486
• 出版社/出版日:QYResearch / 2022年7月11日
• レポート形態:英文、PDF、111ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界の皮膚科用CROの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に皮膚科用CROの世界市場のxxx%を占める「ドラッグサービス」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「研究室」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国の皮膚科用CROの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの皮膚科用CRO市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの皮膚科用CRO市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

皮膚科用CROのグローバル主要メーカーには、IQVIA、Covance、Thermo Fisher Scientific、Parexel International Corporation、Charles River Laboratories International、Icon、Medidata Solutions、Syneos Health、Pharmaron、GVK Biosciences Private Limited、Wuxi AppTec、MEDPACE HOLDINGS、ICON、CTI Clinical Trial & Consulting、Bioskin、Proinnovera、Biorasi、Javara、TFS HealthScienceなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

皮膚科用CRO市場は、種類と用途によって区分されます。世界の皮膚科用CRO市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
ドラッグサービス、臨床サービス、前臨床サービス

【用途別セグメント】
研究室、医療用、臨床モニタリング、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 皮膚科用CRO製品概要
- 種類別市場(ドラッグサービス、臨床サービス、前臨床サービス)
- 用途別市場(研究室、医療用、臨床モニタリング、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の皮膚科用CRO販売量予測2017-2028
- 世界の皮膚科用CRO売上予測2017-2028
- 皮膚科用CROの地域別販売量
- 皮膚科用CROの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別皮膚科用CRO販売量
- 主要メーカー別皮膚科用CRO売上
- 主要メーカー別皮膚科用CRO価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(ドラッグサービス、臨床サービス、前臨床サービス)
- 皮膚科用CROの種類別販売量
- 皮膚科用CROの種類別売上
- 皮膚科用CROの種類別価格
・用途別市場規模(研究室、医療用、臨床モニタリング、その他)
- 皮膚科用CROの用途別販売量
- 皮膚科用CROの用途別売上
- 皮膚科用CROの用途別価格
・北米市場
- 北米の皮膚科用CRO市場規模(種類別、用途別)
- 主要国別の皮膚科用CRO市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの皮膚科用CRO市場規模(種類別、用途別)
- 主要国別の皮膚科用CRO市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の皮膚科用CRO市場規模(種類別、用途別)
- 主要国別の皮膚科用CRO市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の皮膚科用CRO市場規模(種類別、用途別)
- 主要国別の皮膚科用CRO市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの皮膚科用CRO市場規模(種類別、用途別)
- 主要国別の皮膚科用CRO市場規模(トルコ、サウジアラビア)
・企業情報
IQVIA、Covance、Thermo Fisher Scientific、Parexel International Corporation、Charles River Laboratories International、Icon、Medidata Solutions、Syneos Health、Pharmaron、GVK Biosciences Private Limited、Wuxi AppTec、MEDPACE HOLDINGS、ICON、CTI Clinical Trial & Consulting、Bioskin、Proinnovera、Biorasi、Javara、TFS HealthScience
・産業チェーン及び販売チャネル分析
- 皮膚科用CROの産業チェーン分析
- 皮膚科用CROの原材料
- 皮膚科用CROの生産プロセス
- 皮膚科用CROの販売及びマーケティング
- 皮膚科用CROの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 皮膚科用CROの産業動向
- 皮膚科用CROのマーケットドライバー
- 皮膚科用CROの課題
- 皮膚科用CROの阻害要因
・主な調査結果

A dermatology CRO is a CRO dedicated to research addressing dermatological diseases, and a contract research organization is an organization that supports a pharmaceutical or biotechnology company in conducting outsourced research services.
Market Analysis and Insights: Global Dermatology CRO Market
The global Dermatology CRO market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Discover Drug Services accounting for % of the Dermatology CRO global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Laboratory segment is altered to an % CAGR throughout this forecast period.
China Dermatology CRO market size is valued at US$ million in 2021, while the North America and Europe Dermatology CRO are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Dermatology CRO landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dermatology CRO market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dermatology CRO market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dermatology CRO market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dermatology CRO market.
Global Dermatology CRO Scope and Market Size
Dermatology CRO market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Dermatology CRO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Discover Drug Services
Clinical Services
Preclinical Services
Segment by Application
Laboratory
Medical Writing
Clinical Monitoring
Others
By Company
IQVIA
Covance
Thermo Fisher Scientific
Parexel International Corporation
Charles River Laboratories International
Icon
Medidata Solutions
Syneos Health
Pharmaron
GVK Biosciences Private Limited
Wuxi AppTec
MEDPACE HOLDINGS
ICON
CTI Clinical Trial & Consulting
Bioskin
Proinnovera
Biorasi
Javara
TFS HealthScience
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatology CRO Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Discover Drug Services
1.2.3 Clinical Services
1.2.4 Preclinical Services
1.3 Market by Application
1.3.1 Global Dermatology CRO Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Laboratory
1.3.3 Medical Writing
1.3.4 Clinical Monitoring
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Dermatology CRO Market Perspective (2017-2028)
2.2 Dermatology CRO Growth Trends by Region
2.2.1 Dermatology CRO Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Dermatology CRO Historic Market Size by Region (2017-2022)
2.2.3 Dermatology CRO Forecasted Market Size by Region (2023-2028)
2.3 Dermatology CRO Market Dynamics
2.3.1 Dermatology CRO Industry Trends
2.3.2 Dermatology CRO Market Drivers
2.3.3 Dermatology CRO Market Challenges
2.3.4 Dermatology CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dermatology CRO Players by Revenue
3.1.1 Global Top Dermatology CRO Players by Revenue (2017-2022)
3.1.2 Global Dermatology CRO Revenue Market Share by Players (2017-2022)
3.2 Global Dermatology CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dermatology CRO Revenue
3.4 Global Dermatology CRO Market Concentration Ratio
3.4.1 Global Dermatology CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatology CRO Revenue in 2021
3.5 Dermatology CRO Key Players Head office and Area Served
3.6 Key Players Dermatology CRO Product Solution and Service
3.7 Date of Enter into Dermatology CRO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dermatology CRO Breakdown Data by Type
4.1 Global Dermatology CRO Historic Market Size by Type (2017-2022)
4.2 Global Dermatology CRO Forecasted Market Size by Type (2023-2028)
5 Dermatology CRO Breakdown Data by Application
5.1 Global Dermatology CRO Historic Market Size by Application (2017-2022)
5.2 Global Dermatology CRO Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Dermatology CRO Market Size (2017-2028)
6.2 North America Dermatology CRO Market Size by Type
6.2.1 North America Dermatology CRO Market Size by Type (2017-2022)
6.2.2 North America Dermatology CRO Market Size by Type (2023-2028)
6.2.3 North America Dermatology CRO Market Share by Type (2017-2028)
6.3 North America Dermatology CRO Market Size by Application
6.3.1 North America Dermatology CRO Market Size by Application (2017-2022)
6.3.2 North America Dermatology CRO Market Size by Application (2023-2028)
6.3.3 North America Dermatology CRO Market Share by Application (2017-2028)
6.4 North America Dermatology CRO Market Size by Country
6.4.1 North America Dermatology CRO Market Size by Country (2017-2022)
6.4.2 North America Dermatology CRO Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Dermatology CRO Market Size (2017-2028)
7.2 Europe Dermatology CRO Market Size by Type
7.2.1 Europe Dermatology CRO Market Size by Type (2017-2022)
7.2.2 Europe Dermatology CRO Market Size by Type (2023-2028)
7.2.3 Europe Dermatology CRO Market Share by Type (2017-2028)
7.3 Europe Dermatology CRO Market Size by Application
7.3.1 Europe Dermatology CRO Market Size by Application (2017-2022)
7.3.2 Europe Dermatology CRO Market Size by Application (2023-2028)
7.3.3 Europe Dermatology CRO Market Share by Application (2017-2028)
7.4 Europe Dermatology CRO Market Size by Country
7.4.1 Europe Dermatology CRO Market Size by Country (2017-2022)
7.4.2 Europe Dermatology CRO Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dermatology CRO Market Size (2017-2028)
8.2 Asia-Pacific Dermatology CRO Market Size by Type
8.2.1 Asia-Pacific Dermatology CRO Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Dermatology CRO Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Dermatology CRO Market Share by Type (2017-2028)
8.3 Asia-Pacific Dermatology CRO Market Size by Application
8.3.1 Asia-Pacific Dermatology CRO Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Dermatology CRO Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Dermatology CRO Market Share by Application (2017-2028)
8.4 Asia-Pacific Dermatology CRO Market Size by Region
8.4.1 Asia-Pacific Dermatology CRO Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Dermatology CRO Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Dermatology CRO Market Size (2017-2028)
9.2 Latin America Dermatology CRO Market Size by Type
9.2.1 Latin America Dermatology CRO Market Size by Type (2017-2022)
9.2.2 Latin America Dermatology CRO Market Size by Type (2023-2028)
9.2.3 Latin America Dermatology CRO Market Share by Type (2017-2028)
9.3 Latin America Dermatology CRO Market Size by Application
9.3.1 Latin America Dermatology CRO Market Size by Application (2017-2022)
9.3.2 Latin America Dermatology CRO Market Size by Application (2023-2028)
9.3.3 Latin America Dermatology CRO Market Share by Application (2017-2028)
9.4 Latin America Dermatology CRO Market Size by Country
9.4.1 Latin America Dermatology CRO Market Size by Country (2017-2022)
9.4.2 Latin America Dermatology CRO Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dermatology CRO Market Size (2017-2028)
10.2 Middle East & Africa Dermatology CRO Market Size by Type
10.2.1 Middle East & Africa Dermatology CRO Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Dermatology CRO Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Dermatology CRO Market Share by Type (2017-2028)
10.3 Middle East & Africa Dermatology CRO Market Size by Application
10.3.1 Middle East & Africa Dermatology CRO Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Dermatology CRO Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Dermatology CRO Market Share by Application (2017-2028)
10.4 Middle East & Africa Dermatology CRO Market Size by Country
10.4.1 Middle East & Africa Dermatology CRO Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Dermatology CRO Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Details
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Dermatology CRO Introduction
11.1.4 IQVIA Revenue in Dermatology CRO Business (2017-2022)
11.1.5 IQVIA Recent Developments
11.2 Covance
11.2.1 Covance Company Details
11.2.2 Covance Business Overview
11.2.3 Covance Dermatology CRO Introduction
11.2.4 Covance Revenue in Dermatology CRO Business (2017-2022)
11.2.5 Covance Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Dermatology CRO Introduction
11.3.4 Thermo Fisher Scientific Revenue in Dermatology CRO Business (2017-2022)
11.3.5 Thermo Fisher Scientific Recent Developments
11.4 Parexel International Corporation
11.4.1 Parexel International Corporation Company Details
11.4.2 Parexel International Corporation Business Overview
11.4.3 Parexel International Corporation Dermatology CRO Introduction
11.4.4 Parexel International Corporation Revenue in Dermatology CRO Business (2017-2022)
11.4.5 Parexel International Corporation Recent Developments
11.5 Charles River Laboratories International
11.5.1 Charles River Laboratories International Company Details
11.5.2 Charles River Laboratories International Business Overview
11.5.3 Charles River Laboratories International Dermatology CRO Introduction
11.5.4 Charles River Laboratories International Revenue in Dermatology CRO Business (2017-2022)
11.5.5 Charles River Laboratories International Recent Developments
11.6 Icon
11.6.1 Icon Company Details
11.6.2 Icon Business Overview
11.6.3 Icon Dermatology CRO Introduction
11.6.4 Icon Revenue in Dermatology CRO Business (2017-2022)
11.6.5 Icon Recent Developments
11.7 Medidata Solutions
11.7.1 Medidata Solutions Company Details
11.7.2 Medidata Solutions Business Overview
11.7.3 Medidata Solutions Dermatology CRO Introduction
11.7.4 Medidata Solutions Revenue in Dermatology CRO Business (2017-2022)
11.7.5 Medidata Solutions Recent Developments
11.8 Syneos Health
11.8.1 Syneos Health Company Details
11.8.2 Syneos Health Business Overview
11.8.3 Syneos Health Dermatology CRO Introduction
11.8.4 Syneos Health Revenue in Dermatology CRO Business (2017-2022)
11.8.5 Syneos Health Recent Developments
11.9 Pharmaron
11.9.1 Pharmaron Company Details
11.9.2 Pharmaron Business Overview
11.9.3 Pharmaron Dermatology CRO Introduction
11.9.4 Pharmaron Revenue in Dermatology CRO Business (2017-2022)
11.9.5 Pharmaron Recent Developments
11.10 GVK Biosciences Private Limited
11.10.1 GVK Biosciences Private Limited Company Details
11.10.2 GVK Biosciences Private Limited Business Overview
11.10.3 GVK Biosciences Private Limited Dermatology CRO Introduction
11.10.4 GVK Biosciences Private Limited Revenue in Dermatology CRO Business (2017-2022)
11.10.5 GVK Biosciences Private Limited Recent Developments
11.11 Wuxi AppTec
11.11.1 Wuxi AppTec Company Details
11.11.2 Wuxi AppTec Business Overview
11.11.3 Wuxi AppTec Dermatology CRO Introduction
11.11.4 Wuxi AppTec Revenue in Dermatology CRO Business (2017-2022)
11.11.5 Wuxi AppTec Recent Developments
11.12 MEDPACE HOLDINGS
11.12.1 MEDPACE HOLDINGS Company Details
11.12.2 MEDPACE HOLDINGS Business Overview
11.12.3 MEDPACE HOLDINGS Dermatology CRO Introduction
11.12.4 MEDPACE HOLDINGS Revenue in Dermatology CRO Business (2017-2022)
11.12.5 MEDPACE HOLDINGS Recent Developments
11.13 ICON
11.13.1 ICON Company Details
11.13.2 ICON Business Overview
11.13.3 ICON Dermatology CRO Introduction
11.13.4 ICON Revenue in Dermatology CRO Business (2017-2022)
11.13.5 ICON Recent Developments
11.14 CTI Clinical Trial & Consulting
11.14.1 CTI Clinical Trial & Consulting Company Details
11.14.2 CTI Clinical Trial & Consulting Business Overview
11.14.3 CTI Clinical Trial & Consulting Dermatology CRO Introduction
11.14.4 CTI Clinical Trial & Consulting Revenue in Dermatology CRO Business (2017-2022)
11.14.5 CTI Clinical Trial & Consulting Recent Developments
11.15 Bioskin
11.15.1 Bioskin Company Details
11.15.2 Bioskin Business Overview
11.15.3 Bioskin Dermatology CRO Introduction
11.15.4 Bioskin Revenue in Dermatology CRO Business (2017-2022)
11.15.5 Bioskin Recent Developments
11.16 Proinnovera
11.16.1 Proinnovera Company Details
11.16.2 Proinnovera Business Overview
11.16.3 Proinnovera Dermatology CRO Introduction
11.16.4 Proinnovera Revenue in Dermatology CRO Business (2017-2022)
11.16.5 Proinnovera Recent Developments
11.17 Biorasi
11.17.1 Biorasi Company Details
11.17.2 Biorasi Business Overview
11.17.3 Biorasi Dermatology CRO Introduction
11.17.4 Biorasi Revenue in Dermatology CRO Business (2017-2022)
11.17.5 Biorasi Recent Developments
11.18 Javara
11.18.1 Javara Company Details
11.18.2 Javara Business Overview
11.18.3 Javara Dermatology CRO Introduction
11.18.4 Javara Revenue in Dermatology CRO Business (2017-2022)
11.18.5 Javara Recent Developments
11.19 TFS HealthScience
11.19.1 TFS HealthScience Company Details
11.19.2 TFS HealthScience Business Overview
11.19.3 TFS HealthScience Dermatology CRO Introduction
11.19.4 TFS HealthScience Revenue in Dermatology CRO Business (2017-2022)
11.19.5 TFS HealthScience Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer